Litcius/Paper detail

The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.

Swathi V. Kona, Shasi V. Kalivendi

2024Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease16 citationsDOI

Topics & Concepts

MAPK/ERK pathwayCancer researchGlycolysisGene knockdownGlioblastomaTumor progressionBiologyAnaerobic glycolysisGliomaKinaseCell biologyCancerEndocrinologyApoptosisBiochemistryMetabolismGeneticsUbiquitin and proteasome pathwaysMicrotubule and mitosis dynamicsGlioma Diagnosis and Treatment
The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2. | Litcius